Multiple Intravenous Bolus Dosing and Invasive Hemodynamic Assessment in a Hypoxia-Induced Mouse Pulmonary Artery Hypertension Model.

Autor: Qin L; Department of Surgery, Yale University School of Medicine; lingfeng.qin@yale.edu., Jiang B; Department of Vascular Surgery, The First Hospital of China Medical University, Key Laboratory of Pathogenesis, Prevention, and Therapeutics of Aortic Aneurysm., Zsebo K; VasoRx Inc., Duckers HJ; VasoRx Inc., Simons M; Yale Cardiovascular Research Center, Department of Internal Medicine, Yale University School of Medicine; Department of Cell Biology, Yale University School of Medicine., Chen PY; Yale Cardiovascular Research Center, Department of Internal Medicine, Yale University School of Medicine; pei-yu.chen@yale.edu.

Publikováno v: Journal of visualized experiments : JoVE [J Vis Exp] 2022 Nov 11 (189). Date of Electronic Publication: 2022 Nov 11.

哺乳动物多能干细胞：在创建疾病模型、发病机制、药物发现和个性化治疗中的作用.

Autor: 许文强^1,2, 陈浩林³, 颜 昌¹, 徐 涛¹, 谢雅彬¹, 李雪玲²

Publikováno v: Chinese Journal of Tissue Engineering Research / Zhongguo Zuzhi Gongcheng Yanjiu. 1/8/2025, Vol. 29 Issue 1, p136-146. 11p.

Inhibition of the upregulated phosphodiesterase 4D isoforms improves SERCA2a function in diabetic cardiomyopathy.

Autor: Zhu Z; Key Laboratory of Anti-inflammatory and Immune Medicine, Ministry of Education; Collaborative Innovation Center of Anti-inflammatory and Immune Medicine, Institute of Clinical Pharmacology, Anhui Medical University, Hefei, China.; Department of Pharmacology, University of California, Davis, Davis, California, USA., Guan Q; Key Laboratory of Anti-inflammatory and Immune Medicine, Ministry of Education; Collaborative Innovation Center of Anti-inflammatory and Immune Medicine, Institute of Clinical Pharmacology, Anhui Medical University, Hefei, China., Xu B; Department of Pharmacology, University of California, Davis, Davis, California, USA.; Department of Veterans Affairs Northern California Healthcare System, Mather, California, USA., Bahriz S; Department of Pharmacology, University of California, Davis, Davis, California, USA., Shen A; School of Pharmaceutical Sciences and the Fifth Affiliated Hospital, Guangzhou Medical University, Guangzhou, China., West TM; Department of Pharmacology, University of California, Davis, Davis, California, USA., Zhang Y; School of Pharmaceutical Sciences and the Fifth Affiliated Hospital, Guangzhou Medical University, Guangzhou, China., Deng B; Department of Cardiology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China., Wei W; Key Laboratory of Anti-inflammatory and Immune Medicine, Ministry of Education; Collaborative Innovation Center of Anti-inflammatory and Immune Medicine, Institute of Clinical Pharmacology, Anhui Medical University, Hefei, China., Han Y; Department of Emergency Medicine, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, China., Wang Q; Key Laboratory of Anti-inflammatory and Immune Medicine, Ministry of Education; Collaborative Innovation Center of Anti-inflammatory and Immune Medicine, Institute of Clinical Pharmacology, Anhui Medical University, Hefei, China.; Department of Pharmacology, University of California, Davis, Davis, California, USA., Xiang YK; Department of Pharmacology, University of California, Davis, Davis, California, USA.; Department of Veterans Affairs Northern California Healthcare System, Mather, California, USA.

Publikováno v: British journal of pharmacology [Br J Pharmacol] 2024 Dec 11. Date of Electronic Publication: 2024 Dec 11.

Sustained and Efficient Delivery of Antivascular Endothelial Growth Factor by the Adeno‐associated Virus for the Treatment of Corneal Neovascularization: An Outlook for Its Clinical Translation.

Autor: Xie, Mengzhen^1,2 (AUTHOR), Wang, Lixiang¹ (AUTHOR), Deng, Yingping¹ (AUTHOR), Ma, Ke¹ (AUTHOR), Yin, Hongbo¹ (AUTHOR), Zhang, Xiaolan¹ (AUTHOR), Xiang, Xingye^3,4 (AUTHOR), Tang, Jing¹ (AUTHOR) tangjing0802@163.com, Zhou, Yedi (AUTHOR)

Publikováno v: Journal of Ophthalmology. 9/9/2024, Vol. 2024, p1-14. 14p.

Human recombinant stem cell factor stimulates in vitro proliferation of acute myeloid leukemia cells and expands the clonogenic cell pool

Autor: Carlesso, N., Pregno, P., Bresso, P., Gallo, E., Alessandro Pileri, Zsebo, K. M., Ferrero, D.

Publikováno v: Scopus-Elsevier

Stem cell factor (SCF) is a new growth factor acting on early hematopoietic progenitor and stem cells. In our experiments human recombinant SCF stimulated short-term proliferation of accessory cell-depleted acute myeloid leukemia (AML) cells in 13/14

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::dbe651937d04793f04bb393591f05f77
https://pubmed.ncbi.nlm.nih.gov/1378162